NCT06392763View on ClinicalTrials.gov

Care Pathway and Associated Costs of Patients Treated With CAR T-cells Based on SNDS Data

CompletedOBSERVATIONAL
Enrollment

602

Participants

Timeline

Start Date

August 3, 2021

Primary Completion Date

April 28, 2023

Study Completion Date

April 28, 2023

Conditions
Diffuse Large B-cell LymphomaAcute Lymphoblastic Leukemia (ALL)
Trial Locations (1)

92563

Novartis, Rueil-Malmaison

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY